These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8233020)

  • 1. NMDA receptor antagonist CPP inhibits ethanol-evoked ascorbate release in the brain of freely moving rats.
    Wu C
    Neurosci Lett; 1993 Jul; 157(1):111-4. PubMed ID: 8233020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible role of glutamatergic neurotransmission in regulating ethanol-evoked brain ascorbate release.
    Wu C
    Neurosci Lett; 1994 Apr; 171(1-2):105-8. PubMed ID: 7521946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ethanol on ascorbate release in the nucleus accumbens and striatum of freely moving rats.
    Svensson L; Wu C; Johannessen K; Engel JA
    Alcohol; 1992; 9(6):535-40. PubMed ID: 1361740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.
    Lehmann J; Schneider J; McPherson S; Murphy DE; Bernard P; Tsai C; Bennett DA; Pastor G; Steel DJ; Boehm C
    J Pharmacol Exp Ther; 1987 Mar; 240(3):737-46. PubMed ID: 2882014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of dopamine D2 receptor expression by an NMDA receptor antagonist in rat brain.
    Nair VD; Savelli JE; Mishra RK
    J Mol Neurosci; 1998 Oct; 11(2):121-6. PubMed ID: 10096038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (+/-) CPP, an NMDA receptor antagonist, blocks the induction of commissural-CA3 LTP in the anesthetized rat.
    Hernandez RV; Derrick BE; Rodriguez WA; Martinez JL
    Brain Res; 1994 Sep; 656(1):215-9. PubMed ID: 7804841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid changes in ascorbate and dopamine release in rat nucleus accumbens after intracerebroventricular administration of NMDA.
    Svensson L; Wu C; Hulthe P; Johannessen K; Engel JA
    Brain Res; 1992 Jul; 586(2):195-202. PubMed ID: 1521153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of NMDA receptors in the nucleus accumbens elicits spontaneous tail-flicks in rats.
    Millan MJ; Audinot V; Honoré P; Bervoets K; Veiga S; Brocco M
    Eur J Pharmacol; 2000 Jan; 388(1):37-47. PubMed ID: 10657545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cerebral hypoxia on NMDA receptor binding characteristics after treatment with 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) in newborn piglets.
    Fritz KI; Groenendaal F; McGowan JE; Mishra OP; Delivoria-Papadopoulos M
    Brain Res; 1996 Aug; 729(1):66-74. PubMed ID: 8874877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neurosteroid pregnenolone sulfate blocks NMDA antagonist-induced deficits in a passive avoidance memory task.
    Mathis C; Paul SM; Crawley JN
    Psychopharmacology (Berl); 1994 Oct; 116(2):201-6. PubMed ID: 7862949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-methyl-D-aspartate releases gamma-aminobutyric acid from rat striatum in vivo: a microdialysis study using a novel preloading method.
    Young AM; Bradford HF
    J Neurochem; 1993 Feb; 60(2):487-92. PubMed ID: 8093478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioural and neurochemical adaptations to nicotine in rats: influence of NMDA antagonists.
    Shoaib M; Benwell ME; Akbar MT; Stolerman IP; Balfour DJ
    Br J Pharmacol; 1994 Apr; 111(4):1073-80. PubMed ID: 8032593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamatergic regulation of acetylcholine output in different brain regions: a microdialysis study in the rat.
    Giovannini MG; Camilli F; Mundula A; Pepeu G
    Neurochem Int; 1994 Jul; 25(1):23-6. PubMed ID: 7950965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMDA receptor antagonists protect against seizures and wet-dog shakes induced by 4-aminopyridine.
    Fragoso-Veloz J; Tapia R
    Eur J Pharmacol; 1992 Oct; 221(2-3):275-80. PubMed ID: 1426006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NMDA receptor antagonist CPP suppresses long-term potentiation in the rat hippocampal-accumbens pathway in vivo.
    Feasey-Truger KJ; ten Bruggencate G
    Eur J Neurosci; 1994 Aug; 6(8):1247-54. PubMed ID: 7981867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-methyl-D-aspartate releases excitatory amino acids in rat corpus striatum in vivo.
    Young AM; Bradford HF
    J Neurochem; 1991 May; 56(5):1677-83. PubMed ID: 1826519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CPP and amlodipine alter the decrease in basal acetylcholine and choline release by audiogenic stimulus in hippocampus of ethanol-withdrawn rats in vivo.
    Celik T; Kayir H; Ceyhan M; Demirtaş S; Coşar A; Uzbay IT
    Brain Res Bull; 2004 Sep; 64(3):243-9. PubMed ID: 15464861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MK-801 interaction with the 5-HT transporter: a real-time study in brain slices using fast cyclic voltammetry.
    Iravani MM; Muscat R; Kruk ZL
    Synapse; 1999 Jun; 32(3):212-24. PubMed ID: 10340631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous serotonin and serotonin2C receptors are involved in the ability of M100907 to suppress cortical glutamate release induced by NMDA receptor blockade.
    Calcagno E; Carli M; Baviera M; Invernizzi RW
    J Neurochem; 2009 Jan; 108(2):521-32. PubMed ID: 19046357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of three NMDA receptor antagonists in the treatment of prolonged status epilepticus.
    Yen W; Williamson J; Bertram EH; Kapur J
    Epilepsy Res; 2004 Mar; 59(1):43-50. PubMed ID: 15135166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.